Search
for
Sort by
Research 811–840 of 1000+
- Review of the Literature: Topical JAK Inhibitors Showing Promise for Hair Loss!
- 18883 Androgenetic alopecia pattern hair regrowth in patients with alopecia areata treated with oral JAK inhibitors
- The new era of JAK inhibitors: Impelling updates in Alopecia Areata Guideline
- Efficacy of JAK inhibitors in the treatment of alopecia: A case report of 10 patients
- 126 Itch of Dermatomyositis treated with topical JAK inhibitor
- Strategies for Managing Suboptimal Response to JAK Inhibitors in Alopecia Areata
- Reddit Analysis Reveals Common Questions of Patients with Alopecia Areata about JAK Inhibitors for Hair Loss.
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA
- Differences in activation of β-catenin in outer root sheath cells between the type of JAK inhibitor: An alternative mechanism promoting hair growth by JAK inhibitors in alopecia areata
- TĘTNIAK AORTY NA OSI CZASU – CZY, KIEDY I JAK LECZYĆ
- 75360 Nasal hair (vibrissae) involvement in patients with alopecia areata universalis: preliminary results showing density modification and response to oral JAK inhibitors
- 73192 Consistent Efficacy of Upadacitinib in Alopecia Areata Subgroups: Adult, Pediatric, Severe Disease, and JAK-Refractory Patients — A Meta-Analysis
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- The stem cell niche
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Alopecia areata
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Age-associated inflammation inhibits epidermal stem cell function
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- Janus kinase inhibitors in dermatology: A systematic review
- Topical Ruxolitinib for the Treatment of Alopecia Universalis
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies
- Tofacitinib for the treatment of lichen planopilaris: A case series
- The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers